1 PHM142 Metabolic Biochemistry and Immunology WHITE CELLS CHEMICAL WARFARE lecture outline 1) Molecular mechanisms of leukocyte function (live 2 days) • Rheumatoid arthritis • Chronic Granulomatous Disease CGD 2) Eosinophils-live 8-12 days when activated (live 8-12 days when not activated). Contain peroxidase, RNase, DNase, lipase 3) Macrophages (greek:big eaters; 21um), amoeboid movement Phagocytose foreign cells AND produce growth factors and cytokines • But macrophages also induce tissue injury
30
Embed
PHM142 Metabolic Biochemistry and Immunology WHITE CELLS CHEMICAL WARFARE lecture outline
PHM142 Metabolic Biochemistry and Immunology WHITE CELLS CHEMICAL WARFARE lecture outline. Molecular mechanisms of leukocyte function (live 2 days) Rheumatoid arthritis Chronic Granulomatous Disease CGD - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
PHM142 Metabolic Biochemistry and Immunology WHITE CELLS
CHEMICAL WARFARE lecture outline1) Molecular mechanisms of leukocyte function (live 2 days)
HOCl + red cell GSH = GSH cyclic sulfonamide (biomarker for HOCl formation in vivo that reflects inflammation (oxidant formed by neutrophils))
5
Living with a killer: The effects of hypochlorite/hypobromite on mammalian cells Chem.Res.Toxicol.21,1011-6 (2008)
6
Activation of leukocyte NADPH oxidase (Nox) showing assembly of the enzyme and fusion of the oxidase-containing vesicle with the phagosomal membrane.
Babior, 2000. American Journal of Medicine. 109:33 44.
7
NADPH oxidase (Nox)Activation DON’T MEMORISE!
Proton Channel Function
Medicine 79, 170-200 (2000)
b558
+ H+
ProtonChannel
(phosphorylationby kinase)
gp91phox is b558 with proton channel (or K+?)
phox is “phagocyte oxidase”
membrane
Vacuolar space
b558
8
bact.
• CGD can kill Bacteria that produce H2O2 and have low catalase activity, e.g., streptococci.• But can’t kill bacteria which have high catalase activity or low H2O2 production, e.g., serratia, nocardia, and aspergillus; fungal, staphylococcus, burkholderia (pneumonia, sepsis).
Rheumatoid Arthritis is an autoimmune inflammatory disease that may affect (skin, blood vessels, heart, lungs, muscles-- but principally attacks joints (proliferative synovitis progressing to cartilage destruction/joint ankylosis.
Pathogenesis (unknown etiology):genetic susceptibility; joint damage mediated by leukocytes or exogenous arthritogen (virus, mycobacteria).
Babior, 2000. American Journal of Medicine. 109:33 44.
NSAID therapy for RA IBUPROPHEN COX-1 inhib. 300mg 3 times perday
Cardiovascular & GI bleeding risk,inhib platelets, kidney/liver tox.
ALEVE (Naproxen) 200mg otc ; lasts 12h
• Inhibits inflammation , COX-I and COX-2 inhibitor
• Decrease pain, temp, muscle pain, menstrual cramps • Lower stroke risk than ibuprofen; high dose risk GI bleed.
VIOXX COX-2 inhibitor for OA,RA 1999 introd.
• 2004 (withdrawn due to heart attack, stroke)
CELEBREX (celecoxib)1998 COX-2 inhib.400mg
• low cardiorenal tox, platelet effects & GI bleeding
11
Side effects of COX-1 inhibitors• e.g. Aspirin may cause stomach bleeding and risk
GI ulcer formation as a result of stomach cell mitochondrial uncoupling and acidosis.
• Rat model: ulcers, intestinal inflammation or gastric permeability induced by indomethacin or DNP + Cox inhib (aspirin).
Aliment Pharmacol. Ther. (2000) 14,639-650
13
14Rheumatoid Arthritis Therapy
Repetitive hypoxia in joints, and endothelial cells
ATP hydrolysis
Hypoxanthine from ATP
ROS
Reperfusion O2 +endothelial cell xanthine oxidase
ALLOPURINOLinhib.
endothelial cell nitric oxide
peroxynitriteDestruction of joint
Uric acidMonosodium urate crystals in joint
15
16
Anti-Inflammation therapy
• ROS Scavenger Therapy SOD, selenomethionine/Vit E, 5-aminosalicylate, penicillamine:Cu • Macrophage inhibitor therapy: Gold thiomalate or auranofin or zinc or copper salicylate• Prostaglandin Synthetase Inhibitors:-(NSAIDS) COX-1 many cells e.g.aspirin,ibuprofen, but GI bleeding,kidney COX-2 inflammatory cells e.g. VIOXX (withdrawn), CELEBREX but
decreases bad prostaglandins, decrease Fe intake References: Semin. Arthritis Rheum. 27: 366-70 (1998). Autoimmunity Reviews 7,1-7(2007) Anti-inflammatory Biologics
17
EOSINOPHILS: (chemical warfare cont.)
Accumulate in parasite infection, asthma, rheumatoid diseases, Hodgkin’s lymphoma and allergic or inflammatory diseases
1)destroy parasitic worms, tumor cells, fungi and bacteria by forming hypobromite
H2O2 + Br- + H+ HOBr (hypobromite) + H2O
2) cytokine production e.g. PAF, LTC4 unlike neutrophils (leukocytes) .
2
Biochem J. 358, 233-239 (2001),
Journal of Biological Chemistry270 (7) 2905-2913(2000).
MPO
• White blood cells within tissue, have a role in innate and adaptive immunity
• They engulf pathogens and debris via phagocytosis, and move around via amoeboid movement
18
19
MACROPHAGES - chemical warfare function
1) Endocytosis and exocytosis via specific receptors for IgG and C3 coated in bacteria2) H2O2 production by NADPH oxidase to kill mycobacteria3) Arachidonate oxidation to prostaglandin4) Cytokine production - upon activation by PDGF a) lipopolysaccharide (endotoxin) TNF- b) immune system activation BCG infection IL-1 c) inflammation or interferon (IFN-) PAF TGF and arginine nitric oxide kill tumor cells
5) endocytosis and delivery to lysosomes (via scavenger receptor) of oxidised LDL (low density lipoprotein) - can result in transformation to foam cell (the basis of the formation of atherosclerotic plaque)
3
Tumor Necrosis Factor (TNFα) as the primary trigger for
Drug induced hepatocyte cytotoxicity caused by activated immune cells releasing cytokines and reactive oxygen species
(Kupffer cells , macrophages ,neutrophils) i
1) Toxic doses of drugs or chemicals injure hepatocytes. Injured hepatocytes release factors that attract Kupffer cells to specificregions of the liver. 2) Additional mononuclear phagocytes are also recruited from blood and bone marrow precursors. 3) Once localised in the liver, the macrophages become activated by hepatocyte-derived factors of endothelial cells. 4) Activated macrophages and endothelial cells release cytokines e.g.TNFα & platelet activating factor prime & activate Kupffer cells which release Reactive Oxygen Species and more cytokines. 5) Some chemoattractants and cytokines can attract and activate neutrophils that also contribute to hepatocyte injury.
22Macrophages and Tissue Injury
Toxicant
Target tissues
Activated macrophagese.g. Kupffer cells
Mediators
Cytotoxicity Amplification
Model for the role of macrophages in tissue injury by generating inflammatory mediators.
4. Biologics: anti-cytokine antibodies • TNF blockers 1)Etanercept for RA • 2) Infliximab (remicade)Crohns disease, • drug antigen?, cancer a chimeric human Fab.
3) Adalimumab (Humira) human monoclonal for macular degen.
4)Stelera for psoriasis, 5 shots p.a.$50K • Rituximab kills ANCA-vasculitis NEJM363,221-232(2010) & CD20 B